4
Changes in Ownership
CRISPR Therapeutics AG Filed Acc 0000950170-25-081361
Options or other derivatives
- Chief Medical Officer acquired 25,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Patel Naimish Chief Medical Officer | 2025-05-30 | Grant or award · Restricted Stock Units | +25,000 | 25,000 | D: show line 1 in the form |
Loading xslF345X05/ownership.xml…